The immunobiology of myeloid-derived suppressor cells in cancer (Q38649547)

5 September 2017

The immunobiology of myeloid-derived suppressor cells in cancer (English)

1 reference

5 September 2017

Farhad Jadidi-Niaragh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26611648%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Mehdi Yousefi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26611648%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Morteza Motallebnezhad

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26611648%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Tohid Gharibi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26611648%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Elmira Safaie Qamsari

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26611648%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Salman Bagheri

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26611648%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

publication date

26 November 2015

1 reference

5 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26611648%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26611648%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26611648%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

1387-1406

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26611648%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s13277-015-4477-9

8 June 2020

exact match

0 references

cites work

Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Downregulation of IL-17-producing T cells is associated with regulatory T cell expansion and disease progression in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Regulatory T cells in chronic lymphocytic leukemia: implication for immunotherapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Chemotherapeutic targeting of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Myeloid-derived suppressor cells in cancer: recent progress and prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Natural Suppressor (NS) Cells, Neonatal Tolerance, and Total Lymphoid Irradiation: Exploring Obscure Relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Systemic bacillus Calmette-Guérin (BCG) activates natural suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

The immunoregulatory role of bone marrow. I. Suppression of the induction of antibody responses to T-dependent and T-independent antigens by cells in the bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Subsets, expansion and activation of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

History of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

The terminology issue for myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

CD15+/CD16low human granulocytes from terminal cancer patients: granulocytic myeloid-derived suppressor cells that have suppressive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Myeloid-derived suppressor cells in B cell malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

The role of myeloid cells in the promotion of tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Altered macrophage differentiation and immune dysfunction in tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Tumor-induced immune dysfunctions caused by myeloid suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Mechanisms and functional significance of tumour-induced dendritic-cell defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Myeloid derived suppressor cells in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Myeloid-derived suppressor cells: linking inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Lung cancer patients' CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Regulation of NK cell function by human granulocyte arginase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

S100A9 a new marker for monocytic human myeloid-derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Coordinated regulation of myeloid cells by tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Targeting immune suppressing myeloid-derived suppressor cells in oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Modulation of the antitumor immune response by complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Immature myeloid cells and cancer-associated immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Human endoplasmic reticulum oxidoreductin 1-α is a novel predictor for poor prognosis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Cancer-associated oxidoreductase ERO1-α drives the production of tumor-promoting myeloid-derived suppressor cells via oxidative protein folding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

STATs in cancer inflammation and immunity: a leading role for STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Tumor-mediated inhibition of dendritic cell differentiation is mediated by down regulation of protein kinase C beta II expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Bv8 regulates myeloid-cell-dependent tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Myeloid-derived suppressor cells regulate T cell and B cell responses during autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Granulocytic myeloid-derived suppressor cells inversely correlate with plasma arginine and overall survival in critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Murine cystathionine gamma-lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Physiological functions of thioredoxin and thioredoxin reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

The thiol redox state of lymphoid organs is modified by immunization: role of different immune cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

IDO expression by dendritic cells: tolerance and tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Nitric oxide and thiol redox regulation of Janus kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Nitric Oxide Regulation of Human Peripheral Blood Mononuclear Cells: Critical Time Dependence and Selectivity for Cytokine versus Chemokine Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Nitric oxide-producing myeloid-derived suppressor cells inhibit vascular E-selectin expression in human squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Peroxynitrite: biochemistry, pathophysiology and development of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Nitric oxide, oxidants, and protein tyrosine nitration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

L-arginine metabolism in myeloid cells controls T-lymphocyte functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Proteomic method identifies proteins nitrated in vivo during inflammatory challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Control of Bcl-2 expression by reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

ADAM17 deficiency by mature neutrophils has differential effects on L-selectin shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Emerging Tim-3 functions in antimicrobial and tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Tim-3, a negative regulator of anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Tumor escape mechanism governed by myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Mononuclear myeloid-derived "suppressor" cells express RAE-1 and activate natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Mast cells boost myeloid-derived suppressor cell activity and contribute to the development of tumor-favoring microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Immune cell promotion of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Regulation of tumor metastasis by myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Myeloid derived suppressor cells and their role in tolerance induction in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Elevated chronic inflammatory factors and myeloid-derived suppressor cells indicate poor prognosis in advanced melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Circulating CD14(+)HLA-DR(-/low) myeloid-derived suppressor cell is an indicator of poor prognosis in patients with ESCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4⁺ T cells from patients with GI malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Psychological stress is associated with altered levels of myeloid-derived suppressor cells in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Deficiency of Kruppel-like factor KLF4 in myeloid-derived suppressor cells inhibits tumor pulmonary metastasis in mice accompanied by decreased fibrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

MicroRNAs: small RNAs with a big role in gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

MicroRNAs: key components of immune regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Physiological and pathological roles for microRNAs in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

MicroRNA-155 and MicroRNA-21 promote the expansion of functional myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

MicroRNA-155 deficiency enhances the recruitment and functions of myeloid-derived suppressor cells in tumor microenvironment and promotes solid tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Both miR-17-5p and miR-20a alleviate suppressive potential of myeloid-derived suppressor cells by modulating STAT3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Reactive oxygen species regulate ERBB2 and ERBB3 expression via miR-199a/125b and DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Regulatory T cells and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Highlights on mechanisms of drugs targeting MDSCs: providing a novel perspective on cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Direct and differential suppression of myeloid-derived suppressor cell subsets by sunitinib is compartmentally constrained

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Myeloid expression of angiotensin-converting enzyme facilitates myeloid maturation and inhibits the development of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Angiotensin-converting enzyme is required for normal myelopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Activation of mTOR pathway in myeloid-derived suppressor cells stimulates cancer cell proliferation and metastasis in lal(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Dopamine inhibits the function of Gr-1+CD115+ myeloid-derived suppressor cells through D1-like receptors and enhances anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Cimetidine suppresses lung tumor growth in mice through proapoptosis of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4477-9

Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine

21 January 2018

1 reference

12 December 2020

Stat 6-dependent induction of myeloid derived suppressor cells after physical injury regulates nitric oxide response to endotoxin

1 reference

12 December 2020

MicroRNA regulons in tumor microenvironment.

1 reference

12 December 2020

Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor

1 reference

12 December 2020

Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer

1 reference

12 December 2020

Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function

1 reference

12 December 2020

STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion

1 reference

12 December 2020

Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation.

1 reference

12 December 2020

Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway

1 reference

12 December 2020

Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response

1 reference

12 December 2020

Transport of cystine and cysteine in mammalian cells

1 reference

12 December 2020

Development of splenic natural suppressor (NS) cells in Ehrlich tumor-bearing mice

1 reference

12 December 2020

Tumor-derived cytokines induce bone marrow suppressor cells that mediate immunosuppression through transforming growth factor beta

1 reference

12 December 2020

Immunological senescence. I. The role of suppressor cells

1 reference

12 December 2020

Subclinical course of cholesteryl ester storage disease in an adult with hypercholesterolemia, accelerated atherosclerosis, and liver cancer

1 reference

12 December 2020

Multimerisation of A disintegrin and metalloprotease protein-17 (ADAM17) is mediated by its EGF-like domain

1 reference

12 December 2020

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

1 reference

12 December 2020

CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1beta-secreting cells

1 reference

12 December 2020

Resection of solid tumors reverses T cell defects and restores protective immunity

1 reference

12 December 2020

A prospective study of plasma total cysteine and risk of breast cancer.

1 reference

12 December 2020

Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion

1 reference

12 December 2020

Expression and function of cystine/glutamate transporter in neutrophils

1 reference

12 December 2020

Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses

1 reference

12 December 2020

Activation of cGMP-dependent protein kinase Ibeta inhibits interleukin 2 release and proliferation of T cell receptor-stimulated human peripheral T cells

1 reference

12 December 2020

Immunosuppressive myeloid-derived suppressor cells can be converted into immunogenic APCs with the help of activated NKT cells: an alternative cell-based antitumor vaccine

1 reference

12 December 2020

Regulating Tumor Myeloid-Derived Suppressor Cells by MicroRNAs

1 reference

12 December 2020

Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway

1 reference

12 December 2020

T cell dysfunction in cancer: role of myeloid cells and tumor cells regulating amino acid availability and oxidative stress

1 reference

12 December 2020

miR-223 suppresses differentiation of tumor-induced CD11b⁺ Gr1⁺ myeloid-derived suppressor cells from bone marrow cells

1 reference

12 December 2020

Effect of plasmacytoma cells on the production of granulocyte-macrophage colony-stimulating activity (GM-CSA) in the spleen of tumor-bearing mice

1 reference

12 December 2020

All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination.

1 reference

12 December 2020

Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells

1 reference

12 December 2020

Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor

1 reference

12 December 2020

Arginase and C-reactive protein as potential serum-based biomarker of head and neck squamous cell carcinoma patients of north east India

1 reference

12 December 2020

Inducible nitric-oxide synthase generates superoxide from the reductase domain

1 reference

12 December 2020

Induction of allograft tolerance after total lymphoid irradiation (TLI): development of suppressor cells of the mixed leukocyte reaction (MLR)

1 reference

12 December 2020

Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.

1 reference

12 December 2020

Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor.

1 reference

12 December 2020

Mechanisms of tumor evasion from the immune response.

1 reference

12 December 2020

Increased frequency of CD8+ and CD4+ regulatory T cells in chronic lymphocytic leukemia: association with disease progression

1 reference

12 December 2020

Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells

1 reference

12 December 2020

Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity

1 reference

12 December 2020

Physiological concentrations of retinoic acid favor myeloid dendritic cell development over granulocyte development in cultures of bone marrow cells from mice

1 reference

12 December 2020

Multiple Low Doses of 5-Fluorouracil Diminishes Immunosuppression by Myeloid Derived Suppressor Cells in Murine Melanoma Model.

1 reference

12 December 2020

Neutral amino acid transport in mouse peritoneal macrophages

1 reference

12 December 2020

10.1007/S13277-015-4477-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26611648%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

8 June 2020

1023620575

0 references

Fatcat ID

release_xbrobmbzpbgffni4p4sgb3g5zm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xbrobmbzpbgffni4p4sgb3g5zm

24 November 2022

mapped directly with Wikidata item

1 reference